Europe
The deal has a flexible framework, which will allow for a variety of projects at different stages of development over several years.
Akari Therapeutics, plc announced new preclinical and human data demonstrating the potential benefits of the dual inhibition of complement (C5) and leukotriene (LTB4) pathways by nomacopan for the treatment of pemphigoid disease (PD).
ICON recognised as top employer for women in anonymous survey of 60,000 employees
HALIX announced that they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.
Cytovation AS and Specialized Medical Services-oncology BV announce that SMS-oncology has been selected as the CRO to conduct the phase I/II clinical trial with CyPep-1 in patients with advanced solid cancers.
Santhera Pharmaceuticals announces that Christoph Rentsch has decided to step down as Chief Financial Officer of Santhera by end of this year, in order to pursue his career outside the Company.
Last week was a particularly busy week for biopharma companies to release information about ongoing clinical trials. Here’s a look.
Tagrisso improved overall survival in lung cancer patients.
Sareum Holdings PLC, the specialist small molecule drug development business notes that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, has announced its financial and operational results for the second quarter 2019 ended 30 June 2019.
Integrated package of new and established services saves time and minimizes risks
PRESS RELEASES